159 related articles for article (PubMed ID: 33847741)
41. The Spectrum of MYC Alterations in Diffuse Large B-Cell Lymphoma.
Xia Y; Zhang X
Acta Haematol; 2020; 143(6):520-528. PubMed ID: 32074595
[TBL] [Abstract][Full Text] [Related]
42. TAK1 is a druggable kinase for diffuse large B-cell lymphoma.
Wu Y; Yang R; Ming Y; Xu Y; Chen H; Yao M; Chen X; Mao R; Fan Y
Cell Biochem Funct; 2019 Apr; 37(3):153-160. PubMed ID: 30907011
[TBL] [Abstract][Full Text] [Related]
43. Establishment and characterization of a novel MYC/BCL2 "double-hit" diffuse large B cell lymphoma cell line, RC.
Pham LV; Lu G; Tamayo AT; Chen J; Challagundla P; Jorgensen JL; Medeiros LJ; Ford RJ
J Hematol Oncol; 2015 Oct; 8():121. PubMed ID: 26515759
[TBL] [Abstract][Full Text] [Related]
44. Targeting BCL10 by small peptides for the treatment of B cell lymphoma.
Bao W; Sun C; Sun X; He M; Yu H; Yan W; Wen F; Zhang L; Yang C
Theranostics; 2020; 10(25):11622-11636. PubMed ID: 33052237
[No Abstract] [Full Text] [Related]
45. Preclinical efficacy and biological effects of the oral proteasome inhibitor ixazomib in diffuse large B-cell lymphoma.
Liu W; Chen J; Tamayo AT; Ruan C; Li L; Zhou S; Shen C; Young KH; Westin J; Davis RE; Hu S; Medeiros LJ; Ford RJ; Pham LV
Oncotarget; 2018 Jan; 9(1):346-360. PubMed ID: 29416618
[TBL] [Abstract][Full Text] [Related]
46. Leveraging gene expression subgroups to classify DLBCL patients and select for clinical benefit from a novel agent.
Risueño A; Hagner PR; Towfic F; Fontanillo C; Djebbari A; Parker JS; Drew CP; Nowakowski GS; Maurer MJ; Cerhan JR; Wei X; Ren Y; Lee CW; Couto S; Wang M; Pourdehnad M; Gandhi AK; Trotter MWB
Blood; 2020 Mar; 135(13):1008-1018. PubMed ID: 31977005
[TBL] [Abstract][Full Text] [Related]
47. Active IKKβ promotes the stability of GLI1 oncogene in diffuse large B-cell lymphoma.
Agarwal NK; Kim CH; Kunkalla K; Konno H; Tjendra Y; Kwon D; Blonska M; Kozloski GA; Moy VT; Verdun RE; Barber GN; Lossos IS; Vega F
Blood; 2016 Feb; 127(5):605-15. PubMed ID: 26603838
[TBL] [Abstract][Full Text] [Related]
48. Curcumin Inhibits the Proliferation, Migration, Invasion, and Apoptosis of Diffuse Large B-Cell Lymphoma Cell Line by Regulating MiR-21/VHL Axis.
Chen L; Zhan CZ; Wang T; You H; Yao R
Yonsei Med J; 2020 Jan; 61(1):20-29. PubMed ID: 31887796
[TBL] [Abstract][Full Text] [Related]
49. Smoothened stabilizes and protects TRAF6 from degradation: A novel non-canonical role of smoothened with implications in lymphoma biology.
Qu C; Kunkalla K; Vaghefi A; Frederiksen JK; Liu Y; Chapman JR; Blonska M; Bernal-Mizrachi L; Alderuccio JP; Lossos IS; Landgraf R; Vega F
Cancer Lett; 2018 Nov; 436():149-158. PubMed ID: 30165192
[TBL] [Abstract][Full Text] [Related]
50. Lenalidomide in Relapsed or Refractory Diffuse Large B-Cell Lymphoma: Is It a Valid Treatment Option?
Mondello P; Steiner N; Willenbacher W; Ferrero S; Ghione P; Marabese A; Pitini V; Cuzzocrea S; Mian M
Oncologist; 2016 Sep; 21(9):1107-12. PubMed ID: 27382029
[TBL] [Abstract][Full Text] [Related]
51. Genome-wide CRISPR screen identifies noncanonical NF-κB signaling as a regulator of density-dependent proliferation.
Fomicheva M; Macara IG
Elife; 2020 Nov; 9():. PubMed ID: 33185187
[TBL] [Abstract][Full Text] [Related]
52. Inhibition of the intrinsic apoptosis pathway downstream of caspase-9 activation causes chemotherapy resistance in diffuse large B-cell lymphoma.
Cillessen SA; Hess CJ; Hooijberg E; Castricum KC; Kortman P; Denkers F; Vos W; van de Wiel MA; Schuurhuis GJ; Ossenkoppele GJ; Meijer CJ; Oudejans JJ
Clin Cancer Res; 2007 Dec; 13(23):7012-21. PubMed ID: 18056177
[TBL] [Abstract][Full Text] [Related]
53. The novel cereblon modulator CC-885 inhibits mitophagy via selective degradation of BNIP3L.
Hao BB; Li XJ; Jia XL; Wang YX; Zhai LH; Li DZ; Liu J; Zhang D; Chen YL; Xu YH; Lee SK; Xu GF; Chen XH; Dang YJ; Liu B; Tan MJ
Acta Pharmacol Sin; 2020 Sep; 41(9):1246-1254. PubMed ID: 32210356
[TBL] [Abstract][Full Text] [Related]
54. Geniposide inhibits proliferation and induces apoptosis of diffuse large B-cell lymphoma cells by inactivating the HCP5/miR-27b-3p/MET axis.
Hu L; Zhao J; Liu Y; Liu X; Lu Q; Zeng Z; Zhu L; Tong X; Xu Q
Int J Med Sci; 2020; 17(17):2735-2743. PubMed ID: 33162801
[TBL] [Abstract][Full Text] [Related]
55. Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs.
Lindner S; Steinebach C; Kehm H; Mangold M; Gütschow M; Krönke J
J Vis Exp; 2019 May; (147):. PubMed ID: 31157769
[TBL] [Abstract][Full Text] [Related]
56. Revealing Temozolomide Resistance Mechanisms via Genome-Wide CRISPR Libraries.
Rocha CRR; Reily Rocha A; Molina Silva M; Rodrigues Gomes L; Teatin Latancia M; Andrade Tomaz M; de Souza I; Karolynne Seregni Monteiro L; Menck CFM
Cells; 2020 Dec; 9(12):. PubMed ID: 33271924
[TBL] [Abstract][Full Text] [Related]
57. Human soluble TRAIL/Apo2L induces apoptosis in a subpopulation of chemotherapy refractory nodal diffuse large B-cell lymphomas, determined by a highly sensitive in vitro apoptosis assay.
Cillessen SA; Meijer CJ; Ossenkoppele GJ; Castricum KC; Westra AH; Niesten P; Muris JJ; Nijdam HF; van der Hem KG; Flens M; Hooijberg E; Oudejans JJ
Br J Haematol; 2006 Aug; 134(3):283-93. PubMed ID: 16848771
[TBL] [Abstract][Full Text] [Related]
58. [Thalidomide therapy in relapsed diffuse large B-cell lymphoma in elderly patients. Three cases].
Wohner N; Varga G; Szloboda P; Farkas P; Masszi A; Horváth L; Szombath G; Várkonyi J; Benedek S; Masszi T
Orv Hetil; 2017 Oct; 158(41):1642-1648. PubMed ID: 29025286
[TBL] [Abstract][Full Text] [Related]
59. Discovery of CRBN E3 Ligase Modulator CC-92480 for the Treatment of Relapsed and Refractory Multiple Myeloma.
Hansen JD; Correa M; Nagy MA; Alexander M; Plantevin V; Grant V; Whitefield B; Huang D; Kercher T; Harris R; Narla RK; Leisten J; Tang Y; Moghaddam M; Ebinger K; Piccotti J; Havens CG; Cathers B; Carmichael J; Daniel T; Vessey R; Hamann LG; Leftheris K; Mendy D; Baculi F; LeBrun LA; Khambatta G; Lopez-Girona A
J Med Chem; 2020 Jul; 63(13):6648-6676. PubMed ID: 32130004
[TBL] [Abstract][Full Text] [Related]
60. β-Elemene suppresses tumor growth of diffuse large B-cell lymphoma through regulating lncRNA HULC-mediated apoptotic pathway.
Hu T; Gao Y
Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32010942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]